Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Cremolini

Showing results (71-80 of 284) with videos related to

Pageof 29
Sort By:
ESMO Open|June 4, 2020
Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT studyJean-Baptiste Bachet, Lucjan Wyrwicz, Timothy Price, et al.
Clinical Medicine Insights. Oncology|August 22, 2020
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality?Emanuela Dell'Aquila, Tea Zeppola, Marco Stellato, et al.
Surgical Oncology|August 23, 2022
Impact of baseline gadoxetic acid-enhanced liver magnetic resonance and diffusion-weighted imaging in resectable colorectal liver metastases: A prospective, monocentric studyRoberto Moretto, Beatrice Borelli, Piero Boraschi, et al.
Eclinicalmedicine|February 23, 2023
Impact of genetic variants involved in the lipid metabolism pathway on progression free survival in patients receiving bevacizumab-based chemotherapy in metastatic colorectal cancer: a retrospective analysis of FIRE-3 and MAVERICC trialsJingyuan Wang, Joshua Millstein, Yan Yang, et al.
Clinical Colorectal Cancer|July 2, 2020
KRAS G12C Metastatic Colorectal Cancer: Specific Features of a New Emerging Target PopulationMarta Schirripa, Floriana Nappo, Chiara Cremolini, et al.
Clinical Colorectal Cancer|April 27, 2019
Metronomic Capecitabine With Cyclophosphamide Regimen in Unresectable or Relapsed Pseudomyxoma PeritoneiAlessandra Raimondi, Salvatore Corallo, Monica Niger, et al.
Cancers|July 8, 2020
Single Nucleotide Polymorphisms in MiRNA Binding Sites of Nucleotide Excision Repair-Related Genes Predict Clinical Benefit of Oxaliplatin in FOLFOXIRI Plus Bevacizumab: Analysis of the TRIBE TrialMitsukuni Suenaga, Marta Schirripa, Shu Cao, et al.
Vaccines|June 24, 2022
Safety and Tolerability of COVID-19 Vaccines in Patients with Cancer: A Single Center Retrospective AnalysisAmedeo Nuzzo, Simona Manacorda, Enrico Sammarco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2017
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer PatientsCarmine Carbone, Geny Piro, Francesca Simionato, et al.
Clinical Colorectal Cancer|October 9, 2018
Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based ChemotherapyRyuma Tokunaga, Shu Cao, Madiha Naseem, et al.
Pageof 29

Showing results (71-80 of 284) with videos related to

Sort By:
Pageof 29
ESMO Open|June 4, 2020
Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT studyJean-Baptiste Bachet, Lucjan Wyrwicz, Timothy Price, et al.
Clinical Medicine Insights. Oncology|August 22, 2020
Anti-EGFR Therapy in Metastatic Small Bowel Adenocarcinoma: Myth or Reality?Emanuela Dell'Aquila, Tea Zeppola, Marco Stellato, et al.
Surgical Oncology|August 23, 2022
Impact of baseline gadoxetic acid-enhanced liver magnetic resonance and diffusion-weighted imaging in resectable colorectal liver metastases: A prospective, monocentric studyRoberto Moretto, Beatrice Borelli, Piero Boraschi, et al.
Eclinicalmedicine|February 23, 2023
Impact of genetic variants involved in the lipid metabolism pathway on progression free survival in patients receiving bevacizumab-based chemotherapy in metastatic colorectal cancer: a retrospective analysis of FIRE-3 and MAVERICC trialsJingyuan Wang, Joshua Millstein, Yan Yang, et al.
Clinical Colorectal Cancer|July 2, 2020
KRAS G12C Metastatic Colorectal Cancer: Specific Features of a New Emerging Target PopulationMarta Schirripa, Floriana Nappo, Chiara Cremolini, et al.
Clinical Colorectal Cancer|April 27, 2019
Metronomic Capecitabine With Cyclophosphamide Regimen in Unresectable or Relapsed Pseudomyxoma PeritoneiAlessandra Raimondi, Salvatore Corallo, Monica Niger, et al.
Cancers|July 8, 2020
Single Nucleotide Polymorphisms in MiRNA Binding Sites of Nucleotide Excision Repair-Related Genes Predict Clinical Benefit of Oxaliplatin in FOLFOXIRI Plus Bevacizumab: Analysis of the TRIBE TrialMitsukuni Suenaga, Marta Schirripa, Shu Cao, et al.
Vaccines|June 24, 2022
Safety and Tolerability of COVID-19 Vaccines in Patients with Cancer: A Single Center Retrospective AnalysisAmedeo Nuzzo, Simona Manacorda, Enrico Sammarco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 17, 2017
Homeobox B9 Mediates Resistance to Anti-VEGF Therapy in Colorectal Cancer PatientsCarmine Carbone, Geny Piro, Francesca Simionato, et al.
Clinical Colorectal Cancer|October 9, 2018
Prognostic Effect of Adenosine-related Genetic Variants in Metastatic Colorectal Cancer Treated With Bevacizumab-based ChemotherapyRyuma Tokunaga, Shu Cao, Madiha Naseem, et al.
Pageof 29